Feb. 20, 2025 -- The FDA has approved a new fast-acting insulin biosimilar to help manage blood sugar in people with diabetes, including children and adults. The product, called Merilog ...

Depending on how quickly they need to lower blood sugar and how long they need to manage it, there are fast-, intermediate-, and long-acting insulins. No. Insulin is mandatory for people with type ...

The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls ...

Merilog is the first rapid-acting biosimilar human analog insulin approved by FDA. Since March 2020, FDA has regulated insulin and a subset of other biological products historically regulated as ...

Merilog, a rapid-acting human insulin analog, is the first rapid-acting insulin biosimilar product approved by the FDA. As a rapid-acting insulin, Merilog helps to lower mealtime blood sugar ...

List prices for drugs often differ from what ... Both Humalog and Insulin Lispro Injection are fast-acting insulins, they are used to control high blood sugar in adults and children with diabetes ...

Biosimilars marketed in the US typically have list prices 15% to 35% lower than ... if needed – at mealtimes for example – with fast-acting insulins. The cost of insulin products has become ...

The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls the new drug “Merilog,” a biosimilar to the widely-used insulin ...